A Study of Evaluating the Use of Ultrasound Shear Wave Imaging in Patients with Liver Fibrosis

Overview

About this study

The purpose of this study is to evaluate an ultrasound technology that may be used to evaluate liver fibrosis.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Both male and female
    • age 18 to 80
    • Healthy volunteers OR
    • Patients who are scheduled for clinically indicated liver MRE for fibrosis staging

Exclusion Criteria:

  • Subjects lacking capacity to consent 
  • Subjects with unreliable ultrasound or MRE measurements.
  • Pregnant women will be excluded.
  • Women of child baring potential will be asked by our study coordinator if they are pregnant.
    • If not sure, a urine pregnancy test will be given to screen the subject at no cost to the subject.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Open for enrollment

Contact information:

Jill Weston

(507) 538-4981

Weston.Jill@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20311345

Mayo Clinic Footer